Cardiff Oncology, Inc.

NasdaqCM:CRDF Stock Report

Market Cap: US$200.4m

Cardiff Oncology Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:CRDF Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Dec 24BuyUS$36,726James LevineIndividual7,716US$5.42
12 Dec 24BuyUS$34,224Renee TannenbaumIndividual10,000US$3.42
11 Dec 24BuyUS$940,199Gary PaceIndividual361,615US$2.60

Insider Trading Volume

Insider Buying: CRDF insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CRDF?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,343,9112.63%
Public Companies2,411,5754.72%
Hedge Funds5,384,61610.5%
Institutions12,894,35225.2%
General Public29,099,29356.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 14.5%.

Top Shareholders

Top 25 shareholders own 39.8% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.5%
Commodore Capital LP
5,384,616US$21.1m0%1.48%
5.35%
BlackRock, Inc.
2,735,581US$10.7m4.08%no data
4.72%
Pfizer Inc.
2,411,575US$9.5m0%no data
4.25%
The Vanguard Group, Inc.
2,171,444US$8.5m1.64%no data
2.07%
Gary Pace
1,059,376US$4.2m51.8%no data
1.82%
Geode Capital Management, LLC
928,232US$3.6m1.93%no data
1.63%
State Street Global Advisors, Inc.
832,652US$3.3m3.43%no data
1.3%
MAI Capital Management, LLC
663,363US$2.6m0.69%0.02%
1.18%
Renaissance Technologies LLC
602,384US$2.4m282%no data
0.97%
Morgan Stanley, Investment Banking and Brokerage Investments
494,943US$1.9m-2.21%no data
0.66%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
337,766US$1.3m536%no data
0.65%
Two Sigma Advisers, LP
331,200US$1.3m60%no data
0.61%
Northern Trust Global Investments
309,603US$1.2m215%no data
0.53%
Assenagon Asset Management S.A.
270,523US$1.1m-77.8%no data
0.48%
William Blair Investment Management, LLC
247,078US$968.5k8.54%no data
0.46%
Acorn Bioventures
235,096US$921.6k0%1.47%
0.37%
GSA Capital Partners LLP
186,650US$731.7k433%0.06%
0.36%
Two Sigma Investments, LP
184,573US$723.5k-15.6%no data
0.33%
BNY Asset Management
171,101US$670.7k48.4%no data
0.3%
Millennium Management LLC
152,685US$598.5k-36.3%no data
0.28%
Marshall Wace LLP
143,026US$560.7k-52.1%no data
0.27%
Avestar Capital, LLC
140,469US$550.6k0%0.06%
0.24%
Charles Schwab Investment Management, Inc.
121,293US$475.5k11.5%no data
0.24%
XTX Holdings Limited, Asset Management Arm
120,384US$471.9k44.3%0.03%
0.22%
Lale White
113,788US$446.0k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 00:34
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cardiff Oncology, Inc. is covered by 10 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Raghuram SelvarajuAegis Capital Corporation
Sung Ji NamAvondale Partners
Bryan BrokmeierCantor Fitzgerald & Co.